awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48022028-07C686EA-8BBB-4D94-B889-0285C79C362C
Q48022028-07C686EA-8BBB-4D94-B889-0285C79C362C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48022028-07C686EA-8BBB-4D94-B889-0285C79C362C
Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer.
P2860
Q48022028-07C686EA-8BBB-4D94-B889-0285C79C362C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48022028-07C686EA-8BBB-4D94-B889-0285C79C362C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a54abbea2a8b5e205c79ce8163f9daa65d67f663
P2860
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study.